Crinetics Pharmaceuticals Inc (CRNX)

Operating Cash Flow Growth

-40.94%

TTM · Period ending:

CRNX logo

CRNX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-40.94%
CRNX TTM Cash from Operations YoY % (-105.29% → -40.94%)
High-resolution chart · PNG

CRNX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Crinetics Pharmaceuticals Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-40.945%
-58.3436%
-67.2443%
-75.0129%
-66.2137%
-46.5807%
-35.8752%
-22.5842%
-12.6234%
-25.3301%
-44.3574%
-58.4099%
-77.7525%
-73.4987%
-30.0458%
-26.0576%
-21.8137%
-17.4625%
-42.8217%
-37.1053%
-34.1301%
-34.7373%
-33.7336%
-52.8799%
-77.7015%
-127.3114%
-138.3524%
-143.9885%
-144.1114%
-116.0133%
-105.2854%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.